Methamphetamine enhances histoplasmosis by immunosuppression of the host

Journal of Infectious Diseases

Volumn 200, Issue 1, 2009, Pages 131-141

  Martinez, Luis R ^a   Mihu, Mircea Radu ^a   Gácser, Attila ^a   Santambrogio, Laura ^a   Nosanchuk, Joshua D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; METHAMPHETAMINE; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; FEMALE; FUNGAL VIRULENCE; FUNGUS GROWTH; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFECTION RISK; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; OPPORTUNISTIC INFECTION; PHAGOCYTOSIS; PHAGOSOME; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; SUBSTANCE ABUSE; SURVIVAL RATE; T LYMPHOCYTE; UNITED STATES; YEAST CELL;

ANIMALS; ANTIGENS, FUNGAL; DISEASE PROGRESSION; FEMALE; HISTOPLASMA; HISTOPLASMOSIS; HUMANS; IMMUNOSUPPRESSION; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; LUNG; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; SUBSTANCE-RELATED DISORDERS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67650751411     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/599328     Document Type: Article

References (46)

1. Deepe GS Jr. Immune response to early and late Histoplasma capsulatum infections. Curr Opin Microbiol 2000; 3:359-62.
2. Newman SL. Macrophages in host defense against Histoplasma capsulatum. Trends Microbiol 1999;7:67-71.
3. Allendorfer R, Brunner GD, Deepe GS Jr. Complex requirements for nascent and memory immunity in pulmonary histoplasmosis. J Immunol 1999; 162:7389-96.
4. Zhou P, Seder RA. CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with Histoplasma capsulatum. J Exp Med 1998; 187:1315-24.
5. Cain JA, Deepe GS Jr. Evolution of the primary immune response to Histoplasma capsulatum in murine lung. Infect Immun 1998; 66: 1473-81.
6. - T cells are key regulators of the severity of reactivation histoplasmosis. J Immunol 2006; 177: 1763-71.
7. Drug and Alcohol Services Information System. Trends in methamphetamine/amphetamine admissions to treatment: 1993-2003. 2006. Available at: http://www.oas.samhsa.gov/2k6/methTX/methTX.htm. Accessed 12 June 2007.
8. Colfax G, Shoptaw S. The methamphetamine epidemic: implications for HIV prevention and treatment. Curr HIV/AIDS Rep 2005; 2:194-9.
9. Urbina A, Jones K. Crystal methamphetamine, its analogues, and HIV infection: medical and psychiatric aspects of a new epidemic. Clin Infect Dis 2004;38:890-4.
10. Ellis RJ, Childers ME, Cherner M, Lazzaretto D, Letendre S, Grant I; HIV Neurobehavioral Research Center Group. Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis 2003;188:1820-6.
11. Gonzales R, Marinelli-Casey P, Shoptaw S, Ang A, Rawson RA. Hepatitis C virus infection among methamphetamine-dependent individuals in outpatient treatment. J Subst Abuse Treat 2006;31:195-202.
12. Meth's impact on HIV epidemic being studied: drug's use is growing problem among MSMs. AIDS Alert 2005; 20:79-80.
13. Carey CL, Woods SP, Rippeth JD, Gonzalez R, Heaton RK, Grant I. Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection. AIDS Behav 2006; 10:185-90.
14. Cherner M, Letendre S, Heaton RK, et al.; HIV Neurobehavioral Research Center Group. Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology 2005; 64: 1343-7.
15. Yu Q, Zhang D, Walston M, et al. Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice. Int Immunopharmacol 2002;2:951-62.
16. In SW, Son EW, Rhee DK, Pyo S. Methamphetamine administration produces immunomodulation in mice. J Toxicol Environ Health A 2005;68:2133-45.
17. Mahajan SD, Hu Z, Reynolds JL, Aalinkeel R, Schwartz SA, Nair MP. Methamphetamine modulates gene expression patterns in monocyte derived mature dendritic cells: implications for HIV-1 pathogenesis. Mol Diagn Ther 2006; 10:257-69.
18. Tallóczy Z, Martinez J, Joset D, et al. Methamphetamine inhibits antigen processing, presentation, and phagocytosis. PLoS Pathog 2008; 4:e28.
19. Newman SL. Macrophages in host defense against Histoplasma capsulatum. Trends Microbiol 1999;7:67-71.
20. Sebghati TS, Engle JT, Goldman WE. Intracellular parasitism by Histoplasma capsulatum: fungal virulence and calcium dependence. Science 2000;290:1368-72.
21. Strasser JE, Newman SL, Ciraolo GM, Morris RE, Howell ML, Dean GE. Regulation of the macrophage vacuolar ATPase and phagosomelysosome fusion by Histoplasma capsulatum. J Immunol 1999; 162: 6148-54.
22. Simon SL, Richardson K, Dacey J, et al. A comparison of patterns of methamphetamine and cocaine use. J Addict Dis 2002;21:35-44.
23. Nosanchuk JD, Steenbergen JN, Shi L, Deepe GS Jr, Casadevall A. Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum. J Clin Investig 2003; 112:1164-75.
24. Zancopé-Oliveira RM, Bragg SL, Hurst SF, Peralta JM, Reiss E. Evaluation of cation exchange chromatography for the isolation of M glycoprotein from histoplasmin. J Med Vet Mycol 1993;31:29-41.
25. Gomez FJ, Allendoerfer R, Deepe GS Jr. Vaccination with recombinant heat shock protein 60 from Histoplasma capsulatum protects mice against pulmonary histoplasmosis. Infect Immun 1995; 63:2587.
26. Shi L, Albuquerque PC, Lazar-Molnar E, et al. A monoclonal antibody to Histoplasma capsulatum alters the intracellular fate of the fungus in murine macrophages. Eukaryot Cell 2008;7:1109-17.
27. Steenbergen JN, Nosanchuk JD, Malliaris SD, Casadevall A. Interaction of Blastomyces dermatitidis, Sporothrix schenckii, and Histoplasma capsulatum with Acanthamoeba castellanii. Infect Immun 2004; 72: 3478-88.
28. Guimarães AJ, Williams DA Sr, Zancope-Oliveira RM, Nosanchuk JD. Protective antibodies to histoplasma capsulatum cell surface antigens: HSP60 and recombinant M antigen [abstract B35]. In: Program and abstracts of the American Society of Microbiology Conference on Dimorphic Fungal Pathogens. Washington DC: American Society for Microbiology, 2006:42.
29. Newman SL, Bucher C, Rhodes J, Bullock WE. Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages: cellular cytoskeleton requirement for attachment and ingestion. J Clin Invest 1990; 85:223-30.
30. Yauch LE, Mansour MK, Shoham S, Rottman JB, Levitz SM. Involvement of CD 14, toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivo. Infect Immun 2004; 72:5373-82.
31. Deepe GS Jr, Gibbons RS, Smulian AG. Histoplasma capsulatum manifests preferential invasion of phagocytic subpopulations in murine lungs. J Leukoc Biol 2008; 84:669-78.
32. Schaffner A, Davis CE, Schaffner T, Markert M, Douglas H, Braude AI. In vitro susceptibility of fungi to killing by neutrophils granulocytes discriminates between primary pathogenecity and opportunism. J Clin Invest 1986;78:511-24.
33. Eissenberg LG, Goldman WE. Histoplasma capsulatum fails to trigger release of superoxide from macrophages. Infect Immun 1987; 55:29-34.
34. Wolf JE, Kerchberger V, Kobayashi GS, Little JR. Modulation of the macrophage oxidative burst by Histoplasma capsulatum. J Immunol 1987; 138:582-6.
35. Eissenberg LG, Goldman WE, Schlesinger PH. Histoplasma capsulatum modulates the acidification of phagolysosomes. J Exp Med 1993; 177: 1605-11.
36. Ding L, Shevach EM. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol 1992;148:3133-9.
37. Gildea LA, Gibbons R, Finkelman FD, Deepe GS Jr. Overexpression of interleukin-4 in lungs of mice impairs elimination of Histoplasma capsulatum. Infect Immun 2003;71:3787-93.
38. Allen HL, Deepe GS Jr. Apoptosis modulates protective immunity to the pathogenic fungus Histoplasma capsulatum. J Clin Invest 2005; 115: 2875-85.
39. Allendoerfer R, Deepe GS Jr. Blockade of endogenous TNF-a exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. J Immunol 1998; 160:6072-82.
40. Allendoerfer R, Biovin GP, Deepe GS Jr. Modulation of immune responses in murine pulmonary histoplasmosis. J Infect Dis 1997; 175: 905-14.
41. γ. J Immunol 1995; 155:785-95.
42. Deepe GS Jr, Gibbons RS. Protective and memory immunity to Histoplasma capsulatum in the absence of IL-10. J Immunol 2003; 171: 5353-62.
43. Nosanchuk JD, Steenbergen JN, Shi L, Deepe GS Jr, Casadevall A. Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum. J Clin Investig 2003; 112:1164-75.
44. Shi L, Albuquerque PC, Lazar-Molnar E, et al. A monoclonal antibody to Histoplasma capsulatum alters the intracellular fate of the fungus in murine macrophages. Eukaryot Cell 2008;7:1109-17.
45. Yuan RR, Spira G, Oh J, Paizi M, Casadevall A, Scharff MD. Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice. Infect Immun 1998;66:1057-62.
46. The Partnership for a Drug-Free America Partnership for a Drug-Free America. 2007. Available at: http://www.drugfree.org/. Accessed 4 August 2008.